Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.18 (2.308%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.80
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Oct 2023 16:37

RNS Number : 5742O
Oxford BioDynamics PLC
03 October 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BD5H8572

Issuer Name

Oxford BioDynamics Plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

SENECA PARTNERS LIMITED

City of registered office (if applicable)

 

Country of registered office (if applicable)

UK

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

PLATFORM SECURITIES NOMINEES LIMITED

WOODSIDE NOMINEES LIMITED

City of registered office (if applicable)

LONDON

Country of registered office (if applicable)

UK

5. Date on which the threshold was crossed or reached

02-OCT-2023

6. Date on which Issuer notified

03-OCT-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.930000

0.000000

4.930000

9,978,822

Position of previous notification (if applicable)

5.720000

0.000000

5.720000

11,578,822

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BD5H8572   

9,978,822

4.930000

Sub Total 8.A

9,978,822

4.930000

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

03-OCT-2023

13. Place Of Completion

Haydock UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEASEDEDKDFFA
Date   Source Headline
11th Apr 202212:00 pmRNSHolding(s) in Company
8th Apr 202210:40 amRNSPDMR Dealing
7th Apr 202210:36 amRNSPDMR Dealing
6th Apr 20224:14 pmRNSPDMR Dealing
6th Apr 20224:03 pmRNSPDMR Dealing
30th Mar 20222:09 pmRNSResults of Annual General Meeting
4th Mar 20229:42 amRNSPDMR Dealing
3rd Mar 20229:58 amRNSPDMR Dealing
1st Mar 20224:16 pmRNSPUBLICATION OF 2021 ANNUAL REPORT
25th Feb 20227:00 amRNSUS launch of EpiSwitch® CiRT for oncology
15th Feb 202210:17 amRNSPDMR Dealing
10th Feb 202211:52 amRNSPDMR Dealing
8th Feb 20223:10 pmRNSHolding(s) in Company
7th Feb 20222:47 pmRNSPDMR Dealing
26th Jan 20229:50 amRNSPDMR Dealing
25th Jan 202211:44 amRNSPDMR Dealing
25th Jan 20227:00 amRNSFinal Results
19th Jan 20229:58 amRNSHolding(s) in Company
14th Jan 20222:36 pmRNSHolding(s) in Company
14th Jan 20227:00 amRNSHolding(s) in Company
13th Jan 202212:00 pmRNSHolding(s) in Company
11th Jan 20229:00 amRNSHolding(s) in Company
10th Jan 20227:02 amRNSHolding(s) in Company
4th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20214:00 pmRNSHolding(s) in Company
24th Dec 202111:40 amRNSPDMR Dealing
23rd Dec 20217:00 amRNSNotice of Results
17th Dec 20217:00 amRNSOBD updates on EpiSwitch CST and CiRT tests
13th Dec 20212:23 pmRNSHolding(s) in Company
13th Dec 202110:12 amRNSPDMR Dealing
1st Dec 202112:00 pmRNSPDMR Dealing
24th Nov 20213:02 pmRNSPDMR Dealing
22nd Nov 202111:00 amRNSPDMR Dealing
18th Nov 20213:16 pmRNSHolding(s) in Company
18th Nov 20213:10 pmRNSPDMR Dealing
18th Nov 202111:53 amRNSHolding(s) in Company
11th Nov 202111:08 amRNSResults of General Meeting
4th Nov 20217:00 amRNSHolding(s) in Company
2nd Nov 202112:22 pmRNSHolding(s) in Company
1st Nov 202112:43 pmRNSTotal Voting Rights
1st Nov 20217:00 amRNSHolding(s) in Company
25th Oct 20212:45 pmRNSOBD raises £3.62 million
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSChange of Registered Office
31st Aug 20217:00 amRNSOxford BioDynamics awarded US FNIH Grant
15th Jun 20211:06 pmRNSPDMR Dealing
15th Jun 20217:00 amRNSHalf-year Report
27th May 20219:00 amRNSNotice of Results
14th May 202110:17 amRNSPDMR Dealing / Grant of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.